CAGNONI PABLO J

CIK 00012057037 companiesWILMINGTON, DE

SEC Profile

Transactions

Companies

Filings

CIK

0001205703

Recent Transactions

50 trades

Tax Payment
INCYTE CORP$INCY
Common Stock
2026-06-01$95.59/sh−25,469→ 240,848 total
Award
INCYTE CORP$INCY
Common Stock
2026-05-06+31,517→ 266,317 total
Sale
INCYTE CORP$INCY
Common Stock
2026-04-17$96.50/sh−18,667→ 262,692 total
Exercise/Conversion
INCYTE CORP$INCY
Common Stock
2026-04-17$71.93/sh+12,590→ 281,359 total
Exercise/Conversion
INCYTE CORP$INCY
Common Stock
2026-04-17$64.25/sh+6,077→ 268,769 total
Exercise/Conversion
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2026-04-17−12,590→ 27,699 total
Exercise/Conversion
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2026-04-17−6,077→ 26,833 total
Award
INCYTE CORP$INCY
Common Stock
2026-04-15+27,892→ 262,692 total
Exercise/Conversion
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2026-03-17−7,166→ 9,102 total
Exercise/Conversion
INCYTE CORP$INCY
Common Stock
2026-03-17$64.25/sh+11,501→ 253,467 total
Exercise/Conversion
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2026-03-17−11,501→ 32,910 total
Exercise/Conversion
INCYTE CORP$INCY
Common Stock
2026-03-17$61.18/sh+7,166→ 241,966 total
Sale
INCYTE CORP$INCY
Common Stock
2026-03-17$94.24/sh−18,667→ 234,800 total
Exercise/Conversion
INCYTE CORP$INCY
Common Stock
2026-02-19$61.18/sh+5,575→ 253,468 total
Exercise/Conversion
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2026-02-19−13,093→ 7,182 total
Exercise/Conversion
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2026-02-19−5,575→ 16,268 total
Exercise/Conversion
INCYTE CORP$INCY
Common Stock
2026-02-19$61.76/sh+13,093→ 247,893 total
Sale
INCYTE CORP$INCY
Common Stock
2026-02-19$100.91/sh−18,668→ 234,800 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2026-01-16+28,475→ 28,475 total
Award
INCYTE CORP$INCY
Common Stock
2025-07-15+17,538→ 234,800 total
Award
INCYTE CORP$INCY
Performance Shares
2025-07-15+43,846→ 43,846 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2025-07-15$68.25/sh−2,628→ 217,262 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2025-07-15+39,471→ 39,471 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2025-07-14$69.98/sh−1,280→ 219,890 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2025-01-17+40,289→ 40,289 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2024-07-15+44,411→ 44,411 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2024-07-15$64.25/sh−749→ 221,170 total
Award
INCYTE CORP$INCY
Common Stock
2024-07-15+19,851→ 221,919 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−141,011→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−17,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−17,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−17,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−30,000→ 0 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2024-01-18+21,843→ 21,843 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2023-07-14+20,275→ 20,275 total
Award
INCYTE CORP$INCY
Common Stock
2023-07-14+9,668→ 202,068 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2023-06-14+17,000→ 17,000 total
Award
INCYTE CORP$INCY
Common Stock
2023-06-05+192,400→ 192,400 total
Award
INCYTE CORP$INCY
Common Stock
2023-06-05+179,613→ 179,613 total
Sale
Rubius Therapeutics, Inc.
Common Stock
2023-02-01$0.25/sh−8,448→ 66,082 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Restricted Stock Units
2023-01-31−25,000→ 75,000 total
Sale
Rubius Therapeutics, Inc.
Common Stock
2023-01-31$0.24/sh−7,240→ 74,530 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Common Stock
2023-01-31+25,000→ 81,770 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Restricted Stock Units
2023-01-29−21,250→ 42,500 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Common Stock
2023-01-29+21,250→ 56,770 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2022-06-14+17,000→ 17,000 total
Sale
Rubius Therapeutics, Inc.
Common Stock
2022-02-01$6.57/sh−6,730→ 35,520 total
Award
Rubius Therapeutics, Inc.
Restricted Stock Units
2022-01-31+100,000→ 100,000 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2022-01-31+365,000→ 365,000 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Restricted Stock Units
2022-01-29−21,250→ 63,750 total

Companies

Recent Filings

Address

1801 AUGUSTINE CUT-OFF

WILMINGTON, DE, 19083

View on SEC.gov